Tg Therapeutics, INC. (TGTX) — 8-K Filings

8-K Filings (11)

• TG Therapeutics Files 8-K on Operations and Financials — Nov 3, 2025 Risk: low
  On November 3, 2025, TG Therapeutics, Inc. filed an 8-K report detailing results of operations and financial condition. The filing also includes financial state
• TG Therapeutics Files 8-K: Operations & Financials — Aug 4, 2025 Risk: low
  On August 4, 2025, TG Therapeutics, Inc. filed an 8-K report detailing results of operations and financial condition, along with financial statements and exhibi
• TG Therapeutics Files 8-K on Shareholder Votes & Financials — Jun 13, 2025 Risk: low
  On June 12, 2025, TG Therapeutics, Inc. filed an 8-K report detailing the submission of matters to a vote of security holders and financial statements. The comp
• TG Therapeutics Files 8-K on Operations and Financials — May 5, 2025 Risk: low
  On May 5, 2025, TG Therapeutics, Inc. filed an 8-K report. The filing indicates that the company is providing information regarding its results of operations an
• TG Therapeutics Files 8-K — Jan 14, 2025 Risk: low
  TG Therapeutics, Inc. filed an 8-K on January 14, 2025, to report a Regulation FD Disclosure and Financial Statements and Exhibits. The filing does not contain
• TG Therapeutics Files 8-K on Operations and Financials — Nov 4, 2024 Risk: low
  TG Therapeutics, Inc. filed an 8-K on November 4, 2024, reporting on its results of operations and financial condition, and including financial statements and e
• TG Therapeutics Terminates Material Agreement — Aug 6, 2024 Risk: medium
  On August 2, 2024, TG Therapeutics, Inc. announced the termination of its Material Definitive Agreement with a third party, effective immediately. The company a
• TG Therapeutics Files 8-K: Director Changes & Officer Compensation Updates — Jun 17, 2024 Risk: medium
  TG Therapeutics, Inc. filed an 8-K on June 14, 2024, reporting on several key events. These include the departure of a director, the election of new directors,
• TG Therapeutics Files 8-K Report — May 1, 2024 Risk: low
  On May 1, 2024, TG Therapeutics, Inc. filed an 8-K report detailing its financial results and operations. The company, previously known as Manhattan Pharmaceuti
• TG Therapeutics Files 8-K for Financial Update — Feb 28, 2024 Risk: medium
  TG Therapeutics, Inc. (CIK: 0001001316) filed an 8-K on February 28, 2024, reporting an event on the same date. This filing indicates the company is providing i
• TG Therapeutics Files 8-K on Material Definitive Agreement — Jan 10, 2024
  TG Therapeutics, Inc. filed an 8-K on January 10, 2024, reporting an event that occurred on January 7, 2024, related to an entry into a material definitive agre

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX